Back to Stakeholders

The Cambridge Psychedelic Research Group (CPRG) is a collaborative initiative aimed at accelerating the development of innovative psychedelic therapies. Led by Dr. Liliana Galindo, the group conducts multidisciplinary research and clinical trials for severe mental health conditions, including PTSD and treatment-resistant depression.

Academic Research

0 papers

Published Papers

0

Trial Involvement

0

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
academic
HQ
University of Cambridge, United Kingdom
Website
Visit